These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

622 related items for PubMed ID: 20116088

  • 1. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
    Thomas CM, Kerkmeijer LG, Ariaens HJ, van der Steen RC, Massuger LF, Sweep FC.
    Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088
    [Abstract] [Full Text] [Related]

  • 2. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG, Wielsma S, Massuger LF, Sweep FC, Thomas CM.
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [Abstract] [Full Text] [Related]

  • 3. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S, Kerkmeijer L, Bekkers R, Pyman J, Tan J, Quinn M.
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [Abstract] [Full Text] [Related]

  • 4. Prediction of persistent gestational trophobalstic neoplasia: the role of hCG level and ratio in 2 weeks after evacuation of complete mole.
    Kang WD, Choi HS, Kim SM.
    Gynecol Oncol; 2012 Feb; 124(2):250-3. PubMed ID: 22094931
    [Abstract] [Full Text] [Related]

  • 5. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
    Wolfberg AJ, Berkowitz RS, Goldstein DP, Feltmate C, Lieberman E.
    Obstet Gynecol; 2005 Sep; 106(3):548-52. PubMed ID: 16135585
    [Abstract] [Full Text] [Related]

  • 6. Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy.
    Wolfberg AJ, Feltmate C, Goldstein DP, Berkowitz RS, Lieberman E.
    Obstet Gynecol; 2004 Sep; 104(3):551-4. PubMed ID: 15339768
    [Abstract] [Full Text] [Related]

  • 7. Clinical features of early-stage nonhydropic mole for diagnosis of persistent trophoblastic disease.
    Miyoshi J, Ohba T, Fukunaga M, Katabuchi H.
    Obstet Gynecol; 2011 Oct; 118(4):847-53. PubMed ID: 21934448
    [Abstract] [Full Text] [Related]

  • 8. Clinical utility of hyperglycosylated hCG in serum taken before hydatidiform mole evacuation to predict persistent trophoblastic disease.
    Duc HN, van Trommel NE, Sweep FC, Massuger LF, Thomas CM.
    Int J Biol Markers; 2006 Oct; 21(1):45-9. PubMed ID: 16711513
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The serum concentration of specific beta 1-glycoprotein in trophoblastic disease].
    Radikov N.
    Akush Ginekol (Sofiia); 1989 Oct; 28(2):15-9. PubMed ID: 2548413
    [Abstract] [Full Text] [Related]

  • 14. Guidelines following hydatidiform mole: a reappraisal.
    Kerkmeijer L, Wielsma S, Bekkers R, Pyman J, Tan J, Quinn M.
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):112-8. PubMed ID: 16638032
    [Abstract] [Full Text] [Related]

  • 15. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnancies.
    Growdon WB, Wolfberg AJ, Feltmate CM, Goldstein DP, Genest DR, Chinchilla ME, Berkowitz RS, Lieberman ES.
    J Reprod Med; 2006 Nov; 51(11):871-4. PubMed ID: 17165432
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Preevacuation serum CA 125 in complete hydatidiform mole.
    Tangtrakul S, Srisupandit S, Chailurkit LO, Rajatanavin R.
    Gynecol Oncol; 1997 Mar; 64(3):487-9. PubMed ID: 9062156
    [Abstract] [Full Text] [Related]

  • 18. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI, Kacinski BM, Stanley ER.
    Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
    [Abstract] [Full Text] [Related]

  • 19. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
    Chen RJ, Huang SC, Chow SN, Hsieh CY, Hsu HC.
    Br J Obstet Gynaecol; 1994 Apr; 101(4):330-4. PubMed ID: 8199080
    [Abstract] [Full Text] [Related]

  • 20. Identification of patients with persistent trophoblastic disease after complete hydatidiform mole by using a normal 24-hour urine hCG regression curve.
    van Cromvoirt SM, Thomas CM, Quinn MA, McNally OM, Bekkers RL.
    Gynecol Oncol; 2014 Jun; 133(3):542-5. PubMed ID: 24631700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.